These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 20656067)

  • 1. Autoantibodies in patients with Alzheimer's disease: pathogenetic role and potential use as biomarkers of disease progression.
    Colasanti T; Barbati C; Rosano G; Malorni W; Ortona E
    Autoimmun Rev; 2010 Oct; 9(12):807-11. PubMed ID: 20656067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biomarkers of Alzheimer's disease in body fluids.
    Zheng Y; He J; Hong T
    Sci China Life Sci; 2010 Apr; 53(4):490-6. PubMed ID: 20596916
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Redox-reactive autoantibodies in Alzheimer's patients' cerebrospinal fluids: preliminary studies.
    McIntyre JA; Chapman J; Shavit E; Hamilton RL; Dekosky ST
    Autoimmunity; 2007 Jul; 40(5):390-6. PubMed ID: 17612901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomarkers in preclinical Alzheimer's disease.
    Chong MS; Lim WS; Sahadevan S
    Curr Opin Investig Drugs; 2006 Jul; 7(7):600-7. PubMed ID: 16869111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of cerebrospinal fluid (CSF) beta-amyloid (1-42), phosphorylated tau (ptau-181) and total Tau protein in patients with Alzheimer's disease (AD) and other dementia at Siriraj Hospital, Thailand.
    Thaweepoksomboon J; Senanarong V; Poungvarin N; Chakorn T; Siwasariyanon N; Washirutmangkur L; Udompunthuruk S
    J Med Assoc Thai; 2011 Feb; 94 Suppl 1():S77-83. PubMed ID: 21721431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Disease-specific adaptive immune biomarkers in Alzheimer's disease and related pathologies.
    Dorothée G; Sarazin M; Aucouturier P
    Rev Neurol (Paris); 2013 Oct; 169(10):715-8. PubMed ID: 24016465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galanin and α-MSH autoantibodies in cerebrospinal fluid of patients with Alzheimer's disease.
    Costa A; Bini P; Hamze-Sinno M; Moglia A; Franciotta D; Sinforiani E; Ravaglia S; Bole-Feysot C; Hökfelt T; Déchelotte P; Fetissov SO
    J Neuroimmunol; 2011 Dec; 240-241():114-20. PubMed ID: 22078238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune complexes of auto-antibodies against A beta 1-42 peptides patrol cerebrospinal fluid of non-Alzheimer's patients.
    Henkel AW; Dittrich PS; Groemer TW; Lemke EA; Klingauf J; Klafki HW; Lewczuk P; Esselmann H; Schwille P; Kornhuber J; Wiltfang J
    Mol Psychiatry; 2007 Jun; 12(6):601-10. PubMed ID: 17279093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted proteomics in Alzheimer's disease: focus on amyloid-beta.
    Portelius E; Zetterberg H; Gobom J; Andreasson U; Blennow K
    Expert Rev Proteomics; 2008 Apr; 5(2):225-37. PubMed ID: 18466053
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma levels of soluble CD40, together with the decrease of TGF beta 1, as possible differential markers of Alzheimer disease.
    Mocali A; Cedrola S; Della Malva N; Bontempelli M; Mitidieri VA; Bavazzano A; Comolli R; Paoletti F; La Porta CA
    Exp Gerontol; 2004 Oct; 39(10):1555-61. PubMed ID: 15501026
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-cyclic citrullinated peptide antibody (anti-CCP antibody) is present in the sera of patients with dementia of Alzheimer's type in Asian.
    Satoh K; Kawakami A; Shirabe S; Tamai M; Sato A; Tsujihata M; Nagasato K; Eguchi K
    Acta Neurol Scand; 2010 May; 121(5):338-41. PubMed ID: 20002008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Use of CSF biomarkers in the diagnostics of memory diseases].
    Remes A; Leikola M; Majamaa K; Nikkanen M; Ruokonen LI; Rusanen M; Tapiola T; Ylikotila P; Vallittu AM; Pirttilä T
    Duodecim; 2009; 125(20):2215-22. PubMed ID: 19998760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agonistic autoantibodies to the α(1) -adrenergic receptor and the β(2) -adrenergic receptor in Alzheimer's and vascular dementia.
    Karczewski P; Hempel P; Kunze R; Bimmler M
    Scand J Immunol; 2012 May; 75(5):524-30. PubMed ID: 22260197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biomarkers of oxidative and nitrosative damage in Alzheimer's disease and mild cognitive impairment.
    Mangialasche F; Polidori MC; Monastero R; Ercolani S; Camarda C; Cecchetti R; Mecocci P
    Ageing Res Rev; 2009 Oct; 8(4):285-305. PubMed ID: 19376275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel ventriculo-peritoneal shunt in Alzheimer's disease cerebrospinal fluid biomarkers.
    Silverberg GD; Mayo M; Saul T; Carvalho J; McGuire D
    Expert Rev Neurother; 2004 Jan; 4(1):97-107. PubMed ID: 15853620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biomarkers for Alzheimer's disease.
    Sonnen JA; Keene CD; Montine KS; Li G; Peskind ER; Zhang J; Montine TJ
    Expert Rev Neurother; 2007 Aug; 7(8):1021-8. PubMed ID: 17678497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Alzheimer's disease: immunity and diagnosis].
    Herrera-Rivero M; Hernández-Aguilar ME; Manzo J; Aranda-Abreu GE
    Rev Neurol; 2010 Aug; 51(3):153-64. PubMed ID: 20645266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma biomarkers of Alzheimer's disease.
    Kawarabayashi T; Shoji M
    Curr Opin Psychiatry; 2008 May; 21(3):260-7. PubMed ID: 18382225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrospinal fluid biomarkers for Alzheimer's disease.
    Blennow K; Zetterberg H
    J Alzheimers Dis; 2009; 18(2):413-7. PubMed ID: 19661632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.